IRIS
DRAGO, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.878
EU - Europa 9.321
AS - Asia 4.808
AF - Africa 821
SA - Sud America 205
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 20
Totale 34.076
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.079
IT - Italia 2.624
IE - Irlanda 2.471
CN - Cina 2.467
UA - Ucraina 2.143
SG - Singapore 1.930
CA - Canada 781
RU - Federazione Russa 618
CI - Costa d'Avorio 503
SE - Svezia 412
DE - Germania 351
SN - Senegal 273
BR - Brasile 178
GB - Regno Unito 120
FR - Francia 116
VN - Vietnam 110
IN - India 108
CH - Svizzera 83
FI - Finlandia 61
NL - Olanda 50
AT - Austria 49
BE - Belgio 41
ES - Italia 39
GR - Grecia 38
UZ - Uzbekistan 37
IR - Iran 36
CZ - Repubblica Ceca 34
LB - Libano 32
NG - Nigeria 29
EU - Europa 22
PL - Polonia 22
AU - Australia 15
BG - Bulgaria 15
KR - Corea 13
MX - Messico 13
JP - Giappone 12
IQ - Iraq 9
HK - Hong Kong 8
TR - Turchia 8
AR - Argentina 7
CO - Colombia 7
IL - Israele 7
ZA - Sudafrica 7
EC - Ecuador 6
HR - Croazia 5
NZ - Nuova Zelanda 5
BD - Bangladesh 4
DK - Danimarca 4
PK - Pakistan 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
TW - Taiwan 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BS - Bahamas 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
ID - Indonesia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SM - San Marino 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 34.076
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.226
Chandler 2.517
Jacksonville 2.469
Dublin 2.459
Singapore 1.301
Boardman 1.128
Chicago 961
Catania 747
Nanjing 741
Houston 710
Lawrence 665
Cambridge 663
Andover 653
Toronto 612
Abidjan 503
Ashburn 406
Des Moines 343
San Mateo 320
Wilmington 283
Dakar 273
Civitanova Marche 259
Nanchang 226
Shenyang 201
Hebei 169
Saint Petersburg 166
Jiaxing 165
Ottawa 156
Changsha 139
Florence 133
Tianjin 132
Bremen 112
Dong Ket 88
Messina 87
Grafing 80
Los Angeles 71
Rome 68
Palermo 58
Washington 55
Beijing 51
Liberty Lake 49
Moscow 49
Hangzhou 47
Norwalk 47
Pune 46
Falls Church 45
Seattle 44
Milan 43
Jinan 42
Munich 38
Dearborn 37
Helsinki 35
Brussels 32
Kunming 32
Zhengzhou 32
Ann Arbor 31
Redwood City 31
Leawood 30
Abuja 29
Ningbo 29
Guangzhou 28
Shanghai 28
Aci Catena 25
Ardabil 24
Den Haag 23
Hanoi 22
Naples 22
Tappahannock 21
Padova 19
Redmond 19
Augusta 18
Lappeenranta 18
Frankfurt Am Main 17
Barcelona 16
Brno 15
Foggia 15
Siracusa 14
Taizhou 14
Reggio Calabria 13
Vicenza 13
Amsterdam 12
Hyderabad 12
Lausanne 12
Irvine 11
Mumbai 11
Napoli 11
Campobasso 10
Fuzhou 10
Kiev 10
Madrid 10
Monmouth Junction 10
Phoenix 10
Castelraimondo 9
Ludwigshafen 9
Providence 9
Stockholm 9
Turin 9
Arezzo 8
Bari 8
Biancavilla 8
Changchun 8
Totale 24.754
Salva come PNG Salva come JPEG
Nome #
Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. 522
Current drug treatments targeting dopamine D3 receptor 163
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 152
Dopaminergic-GABAergic interplay and alcohol binge drinking 143
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 140
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 117
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 116
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 114
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 109
Antioxidant and osmoprotecting activity of taurine in dry eye models 108
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 104
Antiproliferative effects of PACAP and VIP in serum-starved glioma cells 101
Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1 98
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 98
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 98
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 97
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 96
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 95
Pericentrin expression in Down's syndrome 94
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System 94
Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key 94
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 92
Antidepressant Drugs and Physical Activity: A Possible Synergism in the Treatment of Major Depression? 91
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 90
Anorectal mucosal melanoma 90
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 89
Dihydroergocryptine improves behavioral deficits of aged male rats 88
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 87
Epigenetic drugs for Alzheimer's disease: hopes and challenges 87
Clinical and neurocognitive predictors of functional outcome in depressed patients with partial response to treatment: One year follow-up study 86
Caffeine Protects Against Retinal Inflammation 85
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 85
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 85
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 84
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 82
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 81
New psychometric strategies for the evaluation of affective, cognitive and psychosocial functioning in unipolar versus bipolar depression: impact of drug treatment 80
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells 80
Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery 80
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 80
Isoflavones: estrogenic activity, biological effect and bioavailability 79
Ruolo fisiologico del monossido d’azoto e monossido di carbonio nella modulazione della pressione endoculare 79
Dopamine D3 receptor, neurofibromin and amyloid precursor protein expression during passive avoidance learning 79
Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene. 79
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 79
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target 79
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 78
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 78
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 78
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 78
P2X7 receptor antagonism: implications in diabetic retinopathy 77
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 76
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 76
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 76
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 76
Thymic factors influence on behavior in rodents 75
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 75
Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice 75
Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain. 74
Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects 74
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 74
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 74
A musician's dystonia 73
Dopamine D3 receptor, neurofibromin and amyloid precursor protein expression during passive avoidance conditioning 73
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 73
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 73
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 73
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 73
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 72
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 72
Farmacologia Oculare 72
Resveratrol in Patients with Minimal Hepatic Encephalopathy 72
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 72
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 71
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 71
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 71
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 71
APP expression in dopamine D3 receptor knock out mice brain during memory consolidation 70
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 70
A key role for TGF-β1 in hippocampal synaptic plasticity and memory 69
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced Diabetes 69
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 69
Screening for Krabbe disease: The first 2 years' experience 69
Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1-42)-induced toxicity 68
13.Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration 68
21. Azione della prolattina e dei suoi frammenti sulle integrazioni psiconeuroendocrine. 68
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 68
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 68
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma 67
A comparison of grooming behavior potencies of neurohypophyseal nonapeptides 67
(-)Deprenyl improves behavioral deficits of aged rats after oral administration. 67
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 67
effects or pyrimidine nucleosides and n-acetyl-glutamine on learning and memory processes in men of various ages 67
treatment of cognitive disturbances in children and elderly with a new pharmacological combination 67
Antiapoptotic effect of the dopamine D3 receptor agonist in malignant peripheral nerve sheath tumor cells 67
Expression profile of parkin isoforms in human gliomas 67
Comparative effects of amitriptyline and amineptine in patients affected by anxious depression 66
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 66
Neurobehavioral syndrome induced by H2-receptor blocker withdrawal: possible role of prolactin 66
Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory 66
Totale 8.701
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.925
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.560 0 0 0 0 0 0 470 24 345 58 483 180
2020/20214.107 60 321 514 44 1.054 155 556 29 378 66 680 250
2021/20224.975 632 709 39 96 772 108 704 168 446 41 168 1.092
2022/20238.150 721 315 78 740 939 1.444 58 1.413 1.986 66 252 138
2023/20243.286 222 466 197 243 137 628 48 197 27 76 663 382
2024/20258.353 156 2.046 816 682 3.030 1.478 145 0 0 0 0 0
Totale 35.300